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Abstract: (239 words) 
Background: Monocytes are versatile cells that can fulfil pro- and anti-inflammatory 
functions when recruited to the liver. Recruited monocytes differentiate into tissue 
macrophages and dendritic cells, which sample antigens and migrate to lymph nodes to elicit 
T-cell responses. The signals that determine monocyte differentiation and the role of hepatic 
sinusoidal endothelial cells (HSEC) in this process are poorly understood. HSEC are known 
to modulate T-cell activation leading us to investigate whether transendothelial migration 
(TEM) of monocytes across HSEC influences their phenotype and function. Materials and 
Methods: Subsets of blood-derived monocytes were allowed to transmigrate across human 
HSEC into a collagen matrix. Most migrated cells remained in the subendothelial matrix but 
~10% underwent spontaneous basal to apical TEM. The maturation, cytokine secretion and 
T-cell stimulatory capacity of reverse transmigrating (RT) and subendothelial (SE) monocytes 
were compared. Results: SE-monocytes were mainly CD16_ whereas 75–80% of RT-
monocytes were CD16+. SE-monocytes derived from the CD14++CD16− subset and 
exhibited high phagocytic activity whereas RT-monocytes originated from CD14++CD16+ 
and CD14+CD16++ monocytes, displayed an immature DC-like phenotype (CD11cposHLA-
DRposCD80loCD86lo) and expressed higher levels of CCR8. Consistent with a DC-phenotype 
RT-monocytes secreted inflammatory cytokines and induced Ag-specific CD4+ T-cell 
activation. In contrast, SE-monocytes suppressed T-cell proliferation and activation and 
exhibited endotoxin tolerance. Transcriptome analysis underscored the functional differences 
between SE and RT-monocytes. Conclusions: Migration across HSEC shapes the 
subsequent fate of monocytes giving rise to anergic macrophage-like cells in tissue and the 
release of immunocompetent pre-DCs into the circulation. 
Key words: liver; immunotolerance; sinusoids; macrophages 
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Introduction: 
Monocytes fulfil important functions in the defense against pathogens by linking innate to 
adaptive immunity.(1) Their plasticity and inherent heterogeneity allows monocytes to give 
rise to tissue-resident macrophages and dendritic cells (DC).(2-5) Macrophage precursor 
cells display phagocytic activity and can clear senescent cells, microbial and other foreign 
material to promote tissue repair and remodeling. During steady-state conditions monocytes 
traverse the endothelium to enter tissue from blood in order to replenish and augment the 
local pool and this process is greatly increased with inflammation.(5) A substantial minority of 
monocytes with a DC-like phenotype sample antigens in the subendothelial compartment 
and migrate to afferent lymph nodes.(2) Human monocytes comprise three morphologically 
and functionally distinct subsets based on expression of CD14 and CD16: ‘classical’ 
CD14++CD16- ; ‘intermediate’ CD14++CD16+ and ‘non-classical’ CD14+CD16++ monocytes.(6, 
7) 
Monocytes traffic to the liver under normal conditions and this increases markedly in 
response to liver injury.(8, 9) We previously showed that monocyte subpopulations 
differentially accumulate in the inflamed liver although the mechanisms that control their 
recruitment and positioning are poorly understood.(10) Hepatic sinusoidal endothelial cells 
(HSEC) differ morphologically and functionally from endothelial cells in other vascular beds 
and actively control the translocation of circulating immune cells from the sinusoids into the 
liver parenchyma.(11) .(12) Importantly, HSEC modulate local immunity by, for instance, 
skewing Th1 and Th17 responses to  to induce suppressive T-cells thereby contributing to 
the prevailing immune regulatory hepatic microenvironment.(13, 14) We hypothesized that 
transendothelial migration across activated HSEC shapes monocyte fate and differentiation 
thereby regulating hepatic immune responses. 
Because monocytes not only migrate from blood into tissue but also undergo reverse 
transmigration out of tissue into the blood we studied uni- and bidirectional migration of 
monocyte subsets across human HSEC to determine how these processes affect 
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subsequent monocyte function. We report that CD16+ monocytes preferentially undergo 
reverse transmigration after which they can activate CD4+ T-cells whereas monocytes that 
remain in the subendothelial space resemble anti-inflammatory macrophages that promote 
T-cell anergy. Functional differences following transendothelial migration are accompanied 
by substantial changes in the transcriptome. Thus TEM across endothelium contributes to 
hepatic immune regulation.  
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Materials and Methods 
Isolation and culture of endothelial cells: 
HSEC were isolated from human explanted or resected liver and surplus donor tissue as 
previously described.(15) Briefly, parenchymal cells were isolated from collagenase-digested 
tissue over a 33/77% Percoll gradient (Amersham Biosciences, GE Healthcare, Little 
Chalfont, U.K.) and magnetic selection with antibody HEA125 (Progen Biotechnik, Germany) 
used to deplete cholangiocytes followed by anti-CD31 selection of HSEC (Invitrogen, 
Paisley, U.K.) and culture in human endothelial basal growth medium (EBM, Invitrogen), 10% 
(v/v) heat-inactivated AB human serum (HD Supplies, Glasgow, U.K.), 10 ng/ml vascular 
endothelial growth factor (VEGF), and 10 ng/ml hepatocyte growth factor (HGF) (PeproTech, 
Peterborough, U.K.) in collagen-coated culture flasks. All human tissue and blood was 
collected with local research ethics committee approval and patient consent. 
 
Bidirectional monocyte transmigration across HSEC 
Bovine collagen I (Gibco, Life Technologies) 3 mg/ml in 10× MEM medium (Life 
Technologies) pH 7.4 was polymerized in 24-well cell culture standing inserts (pore size 0.4 
µm) at 37°C (Merck Millipore, Watford, UK) equilibrated in supplemented HSEC medium for 
at least 3 days. To study phagocytosis collagen matrix was supplemented with 1x107 
unopsonized fluorescence-labelled Zymosan A BioParticles (Molecular Probes, Invitrogen). 
Collagen gels were coated with 100µl fibronectin at 37°C for 30 min (Invitrogen/Gibco; 50 
µg/ml in PBS) and seeded with HSEC grown until confluence following stimulation with 10 
ng/ml TNFα (Peprotech, UK) and 10 ng/ml /IFN-γ (Peptrotech, UK) for 24h. 2×106 CD14+ 
monocytes or presorted monocyte subsets in EBM/0.1% BSA were layered onto the 
fibronectin-coated collagen plugs. After 1.5 hours non-adherent cells were washed off and 
the media replaced by EBM containing 2.5 % (v/v) heat-inactivated human serum. During the 
subsequent 48h incubation spontaneously reverse transmigrating (RT) monocytes were 
harvested by thoroughly washing off cells from above the endothelial layer with ice-cold PBS/ 
0.5 mM EGTA/ 1% FCS. The collagen plugs containing retained subendothelial (SE) 
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monocytes were gently digested in 20% (v/v) collagenase from Clostridium histolyticum 
(Sigma Aldrich,) and 20% (v/v) heat-inactivated FCS at 37°C for 10 minutes. Digests were 
placed on ice, filtered, and resuspended in PBS/2 mM EDTA/ 1% FCS. We confirmed that 
surface markers were not lost during collagenase digestion (data not shown). Contaminating 
HSEC were depleted with biotinylated Ulex Europaeus Agglutinin I (Vector Laboratories, 
Burlingame, CA) and streptavidin-conjugated Dynabeads© (Life Technologies, Carlsbad, 
CA) and magnetic depletion. In some experiments HUVEC were used as endothelial cells. 
RT and SE-monocytes were counted and subjected to further analysis or in vitro 
experiments. Trypan Blue exclusion confirmed viability. 
 
Statistical analysis 
Student t test and GraphPad Prism software was used to compare numerical variables 
between two groups and one-way analysis of variance followed by Bonferroni’s post-test for 
comparisons between more than two groups. Results are expressed as mean ± standard 
error of the mean. P <0.05 was considered statistically significant. * P<0.05, ** P<0.01, *** 
P<0.001 
 
For further information on materials and methods please refer to supporting data provided 
with the full version of the manuscript 
 
Results 
 
Intrahepatic accumulation of monocytes/macrophages is driven by activated 
endothelial cells 
In order to study the fate of monocytes after transmigration to the subendothelial 
compartment we established a model of monocyte transmigration and reverse transmigration 
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involving primary human HSEC, adapted from Randolph et al.(17) Monocytes were allowed 
to migrate across activated HSEC and a thin layer of fibronectin into a 3D collagen scaffold. 
After depletion of non-migrating cells and 2 days of continued co-culture, resident monocytes 
from the subendothelial compartment (SE-monocytes) and monocytes that underwent 
spontaneous reverse transmigration (RT-monocytes) from the subendothelial compartment 
back through the endothelial layer were harvested. To verify that RT-monocytes had 
sampled the subendothelial compartment, and had not simply detached from the endothelial 
monolayer, we supplemented the collagen scaffold with FITC-labeled zymosan particles and 
tracked the localization of phagocytic monocytes/macrophages. Migration into zymosan-
supplemented collagen increased the number of retained subendothelial cells most of which 
were CD16low. The RT-monocytes contained zymosan albeit at lower levels than the SE-
monocytes and were predominantly CD16high (Figure 1B). Long-time imaging could visualize 
forward and reverse transmigration of monocytes across HSEC under cell-culture conditions 
(supplementary video). In order to confirm that the TEM was an active process we reduced 
migration in both directions by inhibiting JAK-STAT signaling, which is required for 
macrophage TEM (18) (Supplementary Figure S1). Interestingly, direct comparison of cell 
compartimentalization after monocyte TEM across HSEC or HUVEC revealed, that HSEC 
clearly favor subendothelial retention (90% SE-monocytes), whereas HUVEC permitted 
approximately 50% of monocytes to reverse transmigrate (Figure 1C). To mimic the 
inflammatory environment present in the subendothelial compartment during liver disease, 
the collagen matrix was supplemented with conditioned medium of activated primary liver 
myofibroblasts (aLMF). TNFα/IFNγ-stimulation of aLMF led to a profound increase the total 
number of transmigrating cells though the ratio of RT/SE was not significantly altered 
(Supplementary Figure S2). These data demonstrate that after active recruitment across 
HSEC monocytes differentiate into either sessile macrophage-like cells with high phagocytic 
capacity or mobile dendritic-like cells. Recruitment is augmented by cell-derived chemotactic 
stimuli. 
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Reverse transmigrating monocytes express CD16 and can be derived from all 
monocyte subsets 
The majority of SE (mean 78.9% ± 9.8%) monocytes were ‘classical’ CD14++CD16-
monocytes whereas 69.4% (± 12.6%) of RT-monocytes were ‘intermediate’ CD14++CD16+ 
and few were ‘classical’ monocytes. Very few cells in either compartment were non-classical 
CD14+CD16++ cells suggesting that this subset does not readily undergo TEM (Figure 2A). 
Monocytes are highly plastic cells and different subsets represent various states of maturity 
and differentiation prompting us to determine how the different subsets in blood contributed 
to either SE or RT-monocytes. When classical monocytes were used as the starting cell type 
>80% were retained in the SE compartment (80.7% ± 12.6) and fewer cells underwent 
reverse TEM compared with either intermediate and non-classical subsets (Figure 2B,C) 
suggesting that CD16 expression is associated with the ability to undergo RT. Most RT-
monocytes were CD16+ indicating that these cells gain CD16 expression either during TEM 
or in the subendothelial space and that this confers on some cells the ability to undergo 
reverse transendothelial migration (Figure 2C).  
 
Reverse transmigration of monocytes across HSEC imparts a phenotype consistent 
with immature dendritic cells 
We analyzed the different subsets for features of DC differentiation to see if reverse 
transmigration selects monocytes with the capability to become DC and to re-enter the 
vasculature before being recruited to lymph nodes through high endothelial venules.(17) 
Both RT and SE-monocytes expressed high levels of MHC Class II and  CD40 (Figure 3). 
CD86 (B7-2) was expressed at higher levels on SE with little CD80 (B7-1) or CD83 detected 
on either subset. RT-monocytes expressed higher levels of two scavenger receptors: the 
mannose receptor (CD206) and CD163, both of which are associated with alternatively 
activated macrophages while CD206 is also present on immature DCs. Neither RT nor SE 
cells expressed high levels of DC-SIGN (CD209).  The classical macrophage marker CD68 
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was expressed at similar levels on both SE and RT-monocytes. CD11b (Mac-1) and CD11c 
are integrin alpha chains that form heterodimers with CD18 and bind complement and ICAM-
1. CD11c expression is characteristic of DCs and was detected at high levels on RT-
monocytes.  CCR7 and CCR8 regulate homing of DC to the afferent lymph node.(19) CCR8 
was expressed at higher levels on RT-monocytes suggesting that CCR8 might be involved in 
reverse transmigration. There were no detectable differences in expression of CCR7 or 
CCR5 on RT versus SE cells and neither subset expressed CCR2 (data not shown). RT-
monocytes tended to express higher levels of CX3CR1 and macrophage-colony-stimulating 
factor receptor (CD115) both of which are characteristic of DC.(20) Thus SE and RT cells are 
similar in terms of co-stimulatory molecule expression although the RT-monocytes have 
characteristics of promigratory, DC-like cells.  
 
RT but not SE-monocytes induce robust T-cell proliferation  
We compared RT monocyte with SE cells for their ability to induce CD4+ T-cell proliferation, a 
defining feature of DCs. While SE-monocytes had little effect on T-cell proliferation RT-
monocytes induced potent proliferative responses after pulsing with pp65 (Figure 4A). We 
saw a similar although weaker effect in an allogeneic T-cell response (Figure 4B). Thus DC-
like function resides in the RT population. In the presence of SE-monocytes T-cell 
proliferation in response to either OKT3 or CD3/CD28 stimulation was significantly 
suppressed at T-cell ratio/monocyte ratios of 1:1 and below, whereas RT-monocytes 
amplified baseline proliferation of CD4+ T-cells (Figure 4C). The inhibitory effect of SE-
monocytes was not due to the induction of apoptosis in CD4+ T-cells (Figure 4D).  
 
RT-monocytes are capable of inducing CD4+ T-cell activation whereas SE macrophage-
like monocytes dampen activation 
Having observed that RT but not SE-monocytes can induce antigen-specific CD4+ T-cell 
proliferation we next compared the ability of SE and RT-monocytes to drive T-cell activation 
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using CD14+ monocytes from CMV-seropositive donors (Figure 5A). RT-monocytes 
activated CD4+ T-cells as demonstrated by upregulation of the late-activation markers CD25 
and HLA-DR whereas SE-monocytes had no effect on activation and suppressed expression 
of the mid-early T-cell activation marker CD71 (Figure 5B,C). We observed similar effects in 
an allogeneic system (data not shown). To obtain insights into the consequences of T-cell 
activation by RT-monocytes we quantified changes in genes involved in T-cell differentiation. 
SE-monocytes increased expression of NFATC2 (NFAT1), which is linked to CD4+ T-cell 
anergy and suppression along with Fas ligand (FASLG) that triggers activation-induced T-cell 
apoptosis.(21-23) In contradistinction CD4+ T-cells activated by RT-monocytes expressed T-
box transcription factor EOMES (Eomesodermin) and TNFRSF9 (CD137) (5-fold and 4.76-
fold increase, respectively compared with cells stimulated with SE monocyte) (Figure 5D). 
These genes are associated with T cell memory and effector function and promote clonal 
expansion and T cell survival.21,22 Cells co-incubated with RT-monocytes also increased 
expression of several genes that drive Th2 commitment, including IL13, IRF4, GFI1, IL4R 
and IL13RA1 (Figure 5D) whereas genes that counteract Th2 polarization (POU2F2 and 
RUNX1) were more highly expressed in T-cells co-cultivated with SE-monocytes. 
 
Reverse transmigrating monocytes induce effector T-cells with Th1-like features 
To further characterize the CD4+ T-cell antigen-specific response driven by RT-monocytes 
we assessed the release of cytokines by activated T cells upon co-culture with CMV pp65 
exposed autologous RT/SE-monocytes. RT-monocytes induced a significantly higher 
proportion of IFN-γ producing T-cells than SE-monocytes suggesting Th1 polarization 
(Figure 6A) although responding CD4+ T-cells also increased CTLA-4 and FOXP3 
expression, genes that are linked to regulatory T-cells but also upregulated during early T 
cell activation. In line with proliferation assays described above, we suggest that RT-
monocytes induce activated effector CD4+ T-cells rather than a suppressive phenotype 
(Figure 6B,C). Despite a genetic profile compatible with Th2 commitment we failed to detect 
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IL-4 in CD4+ T-cells stimulated with RT-monocytes (Figure 6C). Consistent with local IFN-γ 
secretion the RT-monocytes in the co-cultures showed significantly increased levels of 
programmed death-ligand 1 (which is strongly induced by interferons) compared with SE-
monocytes (Figure 6D), whereas its cognate ligand PD-1 was not regulated on co-cultivated 
CD4+ T-cells (Figure 6E). Comparing HSEC- and HUVEC-shaped monocytes we observed 
that SE-monocytes derived from HUVEC-interaction were able to elicit IFN-γ-secretion by 
autologous CD4+ T-cells indicating that failure to induce trans Th1 response is a unique 
feature of liver-specific endothelium (Figure 6F). We conclude that RT-monocytes effectively 
activate CD4+ T-cells and potentially prime T-helper cell function whereas SE-monocytes 
suppress T cell activation and blunt their differentiation.  
 
Resident subendothelial monocytes fail to mount a pro-inflammatory response upon 
TLR engagement 
Having shown differences in the ability of SE and RT-monocytes to induce T cell activation, 
we compared their ability to respond to TLR engagement. Under baseline conditions after 
24h in vitro culture, RT and SE-monocytes secreted low levels of macrophage migration 
inhibitory factor (MIF), IL-8 and the anti-inflammatory IL-1RA.  SE-monocytes also secreted 
the chemokines CXCL1, CCL2 and CCL5. Neither RT nor SE-monocytes spontaneously 
secreted the pro-inflammatory cytokines IL-1β, TNF-α or IL-6 (Figure 7A,B). Upon LPS 
stimulation both subsets secreted IL-6 showing the potential to respond to TLR-4 
engagement but while RT-monocytes showed a pro-inflammatory response with increased 
IL-1β, TNF-α, IL-6, G-CSF and GM-CSF secretion SE-monocytes were relatively refractory to 
LPS stimulation and failed to produce IL-1β, IL-10, IL-13 or TNF-α (Figure 7A-C). In contrast 
RT-monocytes responded to LPS with increased secretion of CCL3, CCL4, CCL2 and CCL5 
as well as a marked increase in IL-1β and TNF-α secretion. Thus, SE-monocytes display 
phagocytosis, poor T cell stimulation and resistance to LPS whereas RT-monocytes are 
proinflammatory and able to activate T cells (Figure 7A-C).  
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 Functional disparities between RT and SE-monocytes are reflected by extensive 
transcriptional differences.  
To get a more profound insight into the effects of TEM on monocytes we analyzed 
transcriptional differences between RT and SE-monocytes belonging to the different subsets. 
Intermediate CD14++CD16+ contained the most distinct gene signature with 432 genes more 
than 10-fold upregulated and 1179 genes more than 10-fold downregulated when comparing 
SE and RT-monocytes whereas around 200 genes were differentially expressed (> 10-fold) 
between SE and RT-monocytes in both CD14++CD16- and CD14+CD16++ monocytes. RT-
monocytes originating from all subsets displayed increased CCL3, CCL4, CXCL1, CXCL2 
and IL-8, and proinflammatory genes including TNF family members and IL-1 compared with 
SE-monocytes. CD14, which is typically maintained in macrophages that do not follow the 
DC-pathway, was consistently upregulated on SE-monocytes of all subsets. In line with the 
immunosuppressive phenotype of SE-monocytes they expressed 15-fold higher levels of 
SIGLEC-7, a marker of anti-inflammatory macrophages (supp. Table 1-3).  
 
Discussion 
Liver macrophages are a heterogeneous population derived from monocytes recruited via 
the blood and a sessile population of resident Kupffer cells, that arise from local 
precursors.(24) In inflammatory liver disease SE-monocytes are recruited in increased 
numbers from the blood and differentiate into distinct functional subsets of DCs that activate 
adaptive responses and macrophages that regulate inflammation, fibrogenesis and 
resolution.(25) In order to be recruited from blood monocytes must undergo TEM across 
hepatic endothelium before entering tissue and because sinusoidal endothelium can 
modulate T cell activation we proposed that TEM might affect the subsequent differentiation 
and function of monocytes. Recent evidence shows that monocytes can exit inflamed tissues 
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into blood by reverse transmigration from the abluminal to luminal side of the endothelium, a 
process that may also have a major effect on differentiation and function and which has been 
proposed as a route for DC emigration from the liver into lymph nodes.(26) 
We used a model system incorporating human HSEC to show for the first time that 
monocytes are able to undergo bidirectional migration through hepatic endothelium with a 
significant number of transmigrated monocytes migrating back in the abluminal to luminal 
direction. Migratory stimuli from activated liver stromal cells presumably augment monocyte 
recruitment. Migration in both directions was partly dependent on JAK-STAT signaling 
confirming that it is an active process. We suggest that these processes are likely to be 
highly relevant to immune surveillance and inflammatory responses because they determine 
the function of the cells and give rise to important differences between tissue monocytes and 
those that exit the liver through reverse transmigration and may then enter draining lymph 
nodes. 
The phenotype of SE-monocytes (CD163lo, HLA-DRhi, CD86med and CD83neg) was 
reminiscent of subsets of hepatic monocyte-derived macrophages described earlier.(10) 
Furthermore, monocytes that remained in the subendothelial compartment demonstrated 
high phagocytic activity, were largely refractory to LPS treatment and failed to stimulate T-
cell activation whereas RT-monocytes were proinflammatory and induced robust CD4+ T-cell 
activation and proliferation. This is consistent with previous experiments using umbilical vein 
endothelial cells in which CD16+ migratory pre-DCs undergo reverse transmigration and in 
which postmigratory monocytes exhibit features of foam cell macrophages.(17, 27) In our 
study the RT-monocytes were CD16+ and experiments in which the starting population 
consisted of highly pure subsets confirmed that some CD16- cells can became CD16+ during 
the process of RT. This suggests that CD16 expression is associated with a migratory 
phenotype and transcriptome analysis of these cells showed that they secrete a range of 
chemokines which could be involved in autocrine or paracrine migratory responses. The 
CD14++CD16- monocytes that failed to undergo reverse TEM expressed higher levels of 
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STAT2, which is known to counteract differentiation of monocytes to DCs and these cells 
engulfed more zymosan particles than the CD16+ cells that underwent RT consistent with a 
macrophage phagocytic function. (18)  
We found that TEM across HSEC modulates cellular function and phenotype rather than 
simply selecting pre-existing subsets. CD14++CD16- monocytes gained CD16 expression 
during reverse transmigration from the basal to apical side of the endothelium and showed 
reduced inflammatory cytokine secretion when residing in the subendothelial matrix. ‘Non-
classical’ CD16hi monocytes have been reported to be highly motile, crawling along blood 
vessels, and have the highest capacity to elicit T-cell proliferation.(28) We found that a 
considerable proportion of this subset undergoes reverse transmigration and gains the ability 
to activate T cells indicating DC functions. This suggests that after capturing tissue antigens 
they undergo reverse TEM and migrate to draining lymph nodes either via the parasinusoidal 
route described by Matsuno or via blood and high endothelial venules where they activate T 
cell responses.(26) 
Many non-parenchymal hepatic cells including DCs, HSEC and Kupffer cells display 
immunosuppressive properties.(31, 32) Our data suggest that monocytes that cross 
sinusoidal endothelium and are then retained in the subendothelial space contribute to the 
tolerogenic liver environment because they were unable to efficiently activate T cells in 
response to viral or alloantigens. In fact, they suppressed CD4+ T-cell proliferation and were 
refractory to activation via TLR4 similar to entotoxin-tolerant liver myeloid DCs.(29) In terms 
of their poor ability to activate T-cells SE-monocytes in our model share some properties with 
human liver CD11c+CD11b+BDCA1+ myeloid DCs.(30) Nevertheless, we did not observe 
induction of IL-10 producing regulatory T-cells nor Th2 skewed immune response as has 
been described for liver DCs but rather suppression of activation and proliferation associated 
with increased expression of NFATC2.(30-32) These results provide more evidence to 
support the hypothesis that efficient T cell activation in the liver occurs in draining lymph 
nodes whereas activation in the liver itself leads to tolerance.(33) Such a mechanism could 
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contribute to the exhaustion and disappearance of CD4+ T-cell responses seen in viral 
hepatitis.(34) CD14++CD16- SE-monocytes showed a 70-fold upregulation of HLA-E mRNA 
transcription compared to RT-monocytes. HLA-E is a ligand for the inhibitory NK-cell ligand 
CD94/NKG2A suggesting another potential anti-inflammatory mechanism employed by SE-
monocytes.(35) 
Unlike myeloid-derived suppressor cells, SE-monocytes were MHC-IIhi and expressed high 
cell surface levels of the co-stimulatory molecule CD86 and low levels of PDL-1, which can 
induce T-cell-apoptosis. Consistent with this PD-1 and CTLA-4 were not up-regulated in 
CD4+ T-cells stimulated with SE-monocytes and the T cells did not show evidence of 
apoptosis. The molecular mechanisms through which SE-monocytes suppress CD4+ T-cell 
activation warrant further investigation. 
In contrast to their subendothelial counterparts RT-monocytes induced a robust autologous 
and allogeneic CD4+ T-cell response characterized by IFN-γ secretion, T-cell activation and 
proliferation. Our model recapitulates the translocation of migratory hepatic DC to the 
draining afferent secondary tissue that has been described in rats.(26) That HSEC can 
induce such functionally different responses suggests that monocyte/HSEC interactions 
contribute to the balance between systemic immune activation and local suppression of 
inflammatory processes within the liver. In some respects RT-monocytes from our 
experiments resemble monocyte-derived TNF-α/iNOS-producing inflammatory DCs that take 
up antigens in peripheral tissue before migrating to the lymph node and releasing 
inflammatory cytokines.(36, 37) RT-monocytes secreted proinflammatory mediators after 
LPS stimulation consistent with a proinflammatory phenotype and expressed high levels of 
MYD88, which links TLR-mediated signals to NFκB activation. Of note, some genes were 
expressed by all RT-monocytes regardless of their CD14/CD16 status. These included 
CCL3, CCL4 and IL1B, suggesting that reverse transmigration itself activates a specific 
pattern of genes in originally distinct subpopulations. 
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Functionally RT and SE-monocytes resembled CD16- and CD16
+ subsets respectively, due 
to overlapping patterns of cytokine response upon LPS challenge for example.(38,39) 
However, meticulous transcriptome analysis of highly pure sorted subsets indicated that the 
monocyte phenotypes described here are not a consequence of selection of pre-existing 
subsets by HSEC but driven by the transmigration process itself, given the vast differences 
between RT and SE-monocytes derived from the same subset.  
In summary, the outcome of monocyte/HSEC interactions is dichotomous and yields 
immunogenic DC-like cells that potentially drive systemic immune response but also cells 
that resemble regulatory macrophages that dampen local inflammation. We provide evidence 
that the retention of immunosuppressive macrophages might be a unique feature of the 
hepatic endothelium.  Thereby, we provide a novel mechanism through which sinusoidal 
endothelial cells can regulate the balance between immunity and tolerance. 
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Figure legends 
 
Figure 1. Hepatic sinusoidal endothelial cells favour recruitment and subendothelial 
accumulation of CD14+ monocytes. (A) Schematic illustration of a tissue model to study TEM 
of monocytes. Primary HSEC isolated from explanted livers were seeded onto a collagen 3D 
matrix with an interposed fibronectin thin layer and grown to confluence. The HSEC 
monolayer was stimulated with 10 ng/mL of TNF-α /IFN-γ for 24h to enhance immune cell 
recruitment, followed by the addition of freshly purified CD14+ monocytes. Non-migrating 
cells were discarded and the co-culture was continued for a total of 48h. During this period 
spontaneous reverse transmigration across HSEC of a minor fraction of monocytes occurred 
with the majority arising from resident subendothelial monocytes. (B) Collagen matrix was 
supplemented with FITC-labelled zymosan particles. Representative contour plots indicate 
the differential phagocytic capacity RT and SE-monocytes after 48h of cultivation and the 
impact on CD16 expression. (C) Comparison of quantitative RT/SE monocyte distribution 
after bidirectional TEM across either HSEC or HUVEC. Mean and SEM from 3 independent 
experiments; P values from unpaired t-test.  
 
 
Figure 2. Reverse transmigrating monocytes are mainly composed of CD14++CD16+ 
monocytes and originate from CD16+ and CD16- precursor cells (A). Composition of RT and 
SE-monocytes according to differential CD14 and CD16 expression.  The percentage of 
‘classical’ CD14++CD16-, ‘intermediate’ CD14++CD16+ and ‘non-classical’ CD14+CD16++ 
monocyte among RT and SE-monocytes is shown for each experiment (n=7 independent 
experiments with HSEC and monocytes from different donors; P values from paired-test). (B) 
Representative zebra plots of peripheral monocyte subset distribution prior to FACS sorting 
(left figure) and CD14/CD16 expression of sorted monocyte subsets after 48h of bidirectional 
TEM across HSEC (right figures). (C) Stacked columns depicting percentages of SE and RT 
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fractions for each monocyte subset (mean and SEM from N=3 independent experiments) 
(bottom left figure). 
Figure 3. Reverse transmigrating cells exhibit a phenotype reminiscent of immature dendritic 
cells. Depiction of representative histograms / density plots from flow cytometry of various 
surface markers implicated in macrophage / DC phenotype on RT (black line) and SE-
monocytes (light grey). Isotype-matched controls highlighted in dark grey. Bar graphs 
represent mean fluorescence intensity (MFI) (mean, SEM, p-value of paired t-test). 
 
Figure 4. RT-monocytes mount efficient CD4+ T-cell proliferative responses whereas SE 
monocyte elicit T-cell suppression. (A) Representative CFSE plots of proliferating autologous 
CD4+ T-cells after antigen-specific stimulation with RT vs. SE-monocytes at monocyte / T-
cell ratios of 1:50 to 1:5 (left panel). Quantification of proliferating autologous CD4+ T-cells 
after Ag-specific stimulation with RT-monocytes (red) and SE-monocytes (blue) given as 
percentage of total cells (mean, SEM from n=3 independent experiments) (right figure). (B) 
Quantification of proliferating allogeneic CD4+ T-cells after stimulation with RT-monocytes 
(red) vs. SE-monocytes (blue) in a T cell suppression assay given as percentage of total 
cells (mean, SEM from n=5 independent experiments). (C) Representative CFSE plots of 
proliferating CD4+ T-cells after stimulation with immobilized α-CD3 Ab (OKT3) in the 
presence of RT vs. SE-monocytes at T-cell / monocyte ratios of 4:1 to 1:4 (left panel). 
Quantification of n=3 independent experiments (mean, SEM) comparing proliferation 
capacity of OKT3-stimulated CD4+ T-cells in the presence of RT (red) vs. SE-monocytes 
(green). CD3/CD28 bead stimulated CD4+ T-cells co-cultured with SE-monocytes are 
highlighted in blue. Dotted line represents baseline CD4+ T-cell proliferation without OKT3 in 
the absence of monocytes. Dashed line indicates OKT3-stimulated CD4+ T-cell proliferation 
without monocytes (right figure). (D) Representative FACS plot of Annexin V assay after 5d 
of Ag-specific autologous CD4+ T-cell stimulation with RT vs. SE-monocytes, gated on CD4+ 
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T-cells. Lower right quadrant represents early apoptotic cells, cells in top right quadrant are 
late apoptotic / necrotic. 
 
Figure 5. RT-monocytes are capable of inducing CD4+ T-cell activation whereas SE 
counterparts promote anergy in autologous T-cells. (A) Schematic illustration of experiments 
assessing autologous CD4+ T-cell activation by RT and SE-monocytes. After retrieval of SE 
and RT-monocytes of CMV seropositive donors, cells were cultivated with pp65 CMV Ag for 
24h, autologous CD4+ T-cell were added and co-cultured for 5d at monocyte / T-cell ratios of 
1:5 and 1:10 in the presence of recombinant IL-2 (50 IU/mL). (B) Representative FACS dot 
plots of CD25, CD26, CD69, CD71 and HLA-DR expression on CD4+ T-cells after 60h of co-
culture with RT and SE-monocytes or without monocytes. (C) Quantification of T-cell 
activation marker expression. Bar graphs represent percentage of positive cells (mean and 
SEM of 3 to 4 independent experiments, p values from Bonferroni’s post hoc test). (D) 
Transcriptional regulation of genes involved in T helper cell polarization in CD4+ T-cells from 
a CMV seropositve donor stimulated with autologous CMV pp65 bearing SE vs. RT-
monocytes. Genes with at least two-fold regulation are indicated. 
 
Figure 6. RT-monocytes induce multifaceted T-cell response patterns whereas SE-
monocytes promote CD4+ T-cell anergy. (A) Representative FACS plot of intracellular IFN-γ 
expression after Ag-specific stimulation of autologous CD4+ T-cells with RT vs. SE-
monocytes (left panel). Bar graphs depicting quantification of n=9 experiments (mean, SEM, 
p value from paired t-test) (right figure). (B) Exemplary FACS plots of intracellular CTLA-4 (y-
axis) and FOXP3 (x-axis) in CD4+ T-cells co-incubated with either RT or SE-monocytes (left 
panel) Representative histogram of intracellular CTLA-4 expression (grey line denoting 
isotype control, dark line denoting CD4+ T-cells stimulated by SE-monocytes, grey fill 
denoting CD4+ T-cells stimulated by RT-monocytes) and respective statistical analysis. 
(mean of MFI, SEM, n=4 experiments) (right panel). (C) Representative FACS plots of 
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intracellular IL-4 (y-axis) and IL-10 expression (x-axis) after Ag-specific stimulation of 
autologous CD4+ T-cells with RT vs. SE-monocytes (left panel). Bar graphs illustrating 
percentage of IL-10 positive CD4+ T-cells (mean, SEM, n=5 experiments). (D) 
Representative histogram of PD-L1 surface expression on RT vs. SE-monocytes (left figure) 
and respective statistical analysis (mean of MFI, SEM, n=5, p value from paired t-test) (right 
figure). (E) Statistical analysis of PD-1 expression on CD4+ T-cells stimulated with RT vs. 
SE-monocytes (mean, SEM, n=6 experiments, p value from paired t-test). (F) Representative 
contour plot of intracellular CTLA-4 (y-axis) and IFN-γ (x-axis) expression in CD4+ T-cells that 
were stimulated with SE monocytes after TEM across HSEC vs. HUVEC. 
 
Figure 7: Differential release of cytokines / chemokines upon LPS stimulation highlights 
endotoxin resistance of SE-monocytes.  1.2 x 105 SE or RT-monocytes were stimulated with 
either 10 ng/mL of LPS or left unstimulated for 24h in serum-free medium. Conditioned 
media was analyzed for the secretion of chemokines and cytokines. (A) Representative 
images of nitrocellulose membranes with spotted antibodies against several cytokines and 
densitometric quantification (normalized mean pixel density of chemiluminescence) of those 
(B) cytokines and (C) chemokines in supernatants from unstimulated RT (white) / SE (dark 
grey) and stimulated RT (light grey) and SE-monocytes (black). In (A) reference spots for 
normalization are highlighted by white boxes. 
 
 
Figure 8: Diagram of the proposed mechanism. Diapedesis across hepatic sinusoidal 
endothelial cells shapes functional outcome of monocytes that enter the liver via blood 
stream. All three monocyte subsets can transmigrate with the CD14+CD16- subset being 
mostly confined to reside in the subendothelial layer (space of Dissé) whilst CD16+ 
monocytes can undergo reverse transmigration. Activated liver myofibroblasts (aLMF) 
support both recruitment of monocytes as well as as intrahepatic retention of monocytes 
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through soluble factors. Subendolthelial (SE) monocytes are highly phagocytic and display a 
macrophage-like phenotype. Upon LPS stimulation SE monocytes fail to mount a relevant 
proinflammatory response (LPS tolerance) and promote CD4+ T-cell anergy by restraining 
cell activation and proliferation thereby dampening local immune reactions. In turn, reverse 
transmigrating (RT) monocytes exhibit features of immature dendritic cells and probably 
employ CCR8 to exit the liver. RT monocytes are potent antigen-presenting cells and release 
a broad spectrum of proinflammatory cytokines and chemokines upon LPS exposure, which 
enables a robust induction of CD4+ T-cell proliferation/activation governing a Th1-prone 
immune response and microenvironment.  
 
Page 26 of 46
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
  
 
 
 
256x191mm (300 x 300 DPI)  
 
 
Page 27 of 46
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
  
 
 
 
256x385mm (300 x 300 DPI)  
 
 
Page 28 of 46
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
  
 
 
 
441x267mm (300 x 300 DPI)  
 
 
Page 29 of 46
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
  
 
 
 
579x270mm (300 x 300 DPI)  
 
 
Page 30 of 46
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
  
 
 
 
330x249mm (300 x 300 DPI)  
 
 
Page 31 of 46
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
  
 
 
 
256x398mm (300 x 300 DPI)  
 
 
Page 32 of 46
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
  
 
 
 
255x261mm (300 x 300 DPI)  
 
 
Page 33 of 46
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
  
 
 
 
352x264mm (72 x 72 DPI)  
 
 
Page 34 of 46
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
Manuscript Number: HEP-15-1041 
Supporting Data: 
 
Supplemtentary Materials and Methods: 
 
Isolation and culture of human umbilical vein endothelial cells (HUVEC) 
Tissue was collected at the Birmingham Women’s Hospital after informed consent and 
approval by the local research ethics committee. HUVEC were isolated via collagenase 
digestion and umbilical cords according to standard procedures and cultured to confluence in 
Human umbilical vein cells were cultured in complete endothelial media containing 10% 
human AB serum (HD supplies, UK), 10 ng/ml epidermal growth factor (Peprotec, UK) and 
10 mg/ml hydrocortisone (Sigma, UK). 
 
Immune Cell Isolation: 
Blood was obtained from healthy volunteers and CMV seropositive donors. Mononuclear 
cells were isolated using established methods.(16) and monocytes purified using MACS 
isolation and CD14 microbeads  and CD4+ T-cells using CD4 microbeads (Miltenyi Biotec, 
Bergisch-Gladbach, Germany) . Cells were >95% pure by flow cytometry. For 
proliferation/suppression assays CD4+ T-cells were labeled with CellTrace CFSE Cell 
Proliferation (Life Technologies) for 10 min with two subsequent quenching steps. To purify 
monocyte subsets monocytes were enriched using OptiPrep density gradient centrifugation 
and CD14++CD16-, CD14++CD16+ and CD14+CD16++ monocytes isolated by high-speed flow 
cytometric sorting after blocking Fc receptors with normal mouse Ig using conjugated mAb 
against CD14, CD16, and CD15/CD56 (BioLegend) (to exclude contaminating neutrophils 
and NK-cells) followed by sorting using a MoFlo cell sorter (Beckman-Coulter).  
 
Isolation of aLMF and generation of conditioned medium  
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Fifty grams of liver was diced and digested using type-1A collagenase (0.4 _g/mL; Sigma 
Aldrich Ltd, Dorset, UK) followed by mechanical homogenization in a Stomacher 400 
Circulator (Seward, NY). The cell suspension was layered over 33/77 (wt/vol) Percoll 
(Amersham Biosciences, Bucks, UK) gradient and centrifuged for 20 minutes at 2300 rpm. 
Nonparenchymal cells at the interface were retrieved and fibroblasts were purified by 
negative immunomagnetic selection. Cholangiocytes and endothelium were removed by 
immunomagnetic selection with antibodies against HEA-125 (10 _g/mL; Progen Biotechnik, 
Germany), CD31 (10 _g/mL clone JC-07; DAKO, Dorset, UK), and sheep anti-mouse 
Dynabeads (Dynal A.S., Norway). aLMF were plated in gelatin-coated flasks in Dulbecco’s 
modified Eagle medium/10% fetal calf serum and viability was confirmed by trypan blue 
exclusion. Supernatants were generated by seeding 5 × 104 cells per well onto 24-well plates 
(Co-Star; Corning, NY) in 500 μL phenol-red–free RPMI-1640/1% BSA containing 2 
mmol/L L-glutamine, 60 μg/mL benzylpenicillin, and 100 μg/mL streptomycin (all Sigma, 
UK). Stimulated supernatants were generated by treating cells for 48 hours with 10 ng/mL 
tumor necrosis factor α (TNFα), and  interferon (IFN)γ (all Pepro-Tech, UK). 
 
 
Flow cytometry 
Cells were washed in FACS buffer, resuspended and labeled with fluorochrome-conjugated 
Abs at pre-determined dilutions at 4°C in PBS/2% FCS/2 mM EDTA and analyzed on a nine-
color Dako Cyan Flow Cytometer using Summit 4.3 software (DakoCytomation, Glostrup, 
Denmark) and FlowJo 8.7 (TreeStar, Ashland, OR). The following Abs were used for surface 
staining: CD14, CD16, CD68, CD86, CD80, CD83, CD115, CD163, CD40, CD206, CD209, 
PD-L1, CD69 (FN50), CD25 (M-A251), CD127 (HIL-7R-M21), CD71 (M-A712), HLA-DR 
(L243), CD26 (L272), PD-1 (MIH1), αL/CD11a (345913 and HI111), CD11b, CD11c, CCR5 
(2D7/CCR5), CCR7 (3D12), CCR8, CX3CR1 (2A9-1), mouse IgG1 (X40 and MOPC-21), 
mouse IgG2a (G155-178, X39 and MOPC-173), mouse IgG2b (27-35), rat IgG2a (54447), 
Page 36 of 46
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
and rat IgG2b (RTK4530); purchased from BD Pharmingen (Swindon, UK), BioLegend 
(Cambridge, UK), R&D Systems (Minneapolis, MN), eBioscience (Hatfield, UK), or Dako. 
Intracellular staining was performed using the Cytofix/Cytoperm Kit (BD Biosciences) with 
Abs against IFN-γ (B27), IL-4, IL-10 (JES3-19F1) (all BD Pharmingen), CTLA-4 and FoxP3 
(236A/E7, eBioscience). Apoptosis and necrosis were detected using Annexin V (FITC) and 
propidium iodide (BD Pharmingen). 
 
Ag-specific and allogeneic CD4+ T-cell stimulation 
For Ag-specific CD4+ T-cell stimulation monocytes from CMV seropositive donors were 
incubated with CMV pp65 for 24h followed by co-culture with autologous 1x105 CD4+ T-cells 
in a round-bottomed plate in 1640-RPMI plus 10% FCS, 1% GPS and 50 IU/ml IL-2 at 37 °C, 
5% CO2 for 60h. Different ratios were investigated. Alloreactive T-cell activation was done 
using allogeneic CD4+ T-cells. Intracellular cytokines in CD4+ T-cells were analysed after  8h 
Golgi block with Brefeldin. CFSE-labelled CD4+ T-cells were used for proliferation assays.   
 
T-cell suppression assay 
CFSE-labelled 1x105 CD4+ T-cells and RT/SE monocytes were co-cultured in 1640 RPMI at 
different ratios in 96 well round bottom plates in the presence of either CD3/CD28 activating 
beads (Treg inspector; Miltenyi Biotec) or immobilized CD3 Ab (OKT3) to induce T-cell 
proliferation at a 1:1 bead to T-cell ratio. Co-culture was maintained at 37°C, 5% CO2 for 36h 
and FACS analysis used to quantify CD4+ T-cell proliferation.  
 
RT-PCR 
RT2 Profiler PCR Array Human T Helper Cell Differentiation Kit was used to analyse cDNA 
synthesized using a RT2 First Strand Kit from samples isolated by the RNeasy minikit and 
RT2 SYBR Green qPCR Mastermix (all Qiagen). Samples were analyzed on a Lightcycler 
480 II instrument (Roche, Mannheim, Germany) according to the manufacturer’s instruction. 
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Changes in expression of 84 genes associated with T cell differentiation were determined in 
CD4 T cells before and after migration using online RT2 profiler PCR Array Data Analysis 
version 3.5 with normalization for the housekeeping genes ACTB, B2M, GAPDH, HPRT1, 
and RPLP0. 
 
Cytokine Secretion Assay 
1.2 x 105 Rt or SE monocytes cells were cultured in serum-free RPMI 1640 medium in 24-
well plates (Costar) and stimulated with 10 ng/ml LPS (Sigma-Aldrich) or left unstimulated for 
24h. Supernatant was harvested and cytokine secretion assessed using a Cytokine Array Kit, 
Panel A (R&D systems).  
 
 
 
Serial analysis of gene expression 
Barcoded SAGE sequencing libraries were prepared using a SOLiD SAGE Kit with 
Barcoding Adaptor Module (Life Technologies) and sequenced using a SOLiD 4 System next 
generation sequencer (Life Technologies). Sequence reads were mapped to human RefSeq 
release 59 using the SOLiD SAGE v1.10 mapping tool. Tables of tag counts for each sample 
were used to determine differentially regulated genes using Empirical analysis of digital gene 
expression data in R16 running in the Bioconductor environment version 2.14. Tags were 
filtered to select tags in which at least three samples had counts per million greater than 
three. 
 
Long-term imaging of bidirectional monocytic migration across HSEC 
Fibronectin-coated collagen matrix was prepared as described above and added to 24-well 
plate.  7.5x10^5 primary HSEC were seeded onto polymerized collagen plugs in a 24-well 
plate and grown confluent and subsequently stimulated with 10 ng/mL TNFα + IFNγ for 
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24h. Monocytes were purified according to standard procedures. Isolated 2.5x10^5 
monocytes were added and co-cultured for >24h. Monocyte migration across HSEC 
was imaged by a Cell-IQÓ microscope allowing imaging under cell-culture conditions. 
Pictures were taken every 15 minutes.   
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Supplemtentary Figure legends: 
 
Supplementary Figure S1: Monocyte TEM across underlies JAK/STAT activation. Freshly 
purified monocytes were treated with JAK 1 inhibitor or DMSO control at time-point 0 prior to 
TEM across HSEC. Bar graphs depict results of n=5 independent experiments. (mean, SEM, 
paired t-test).  
 
Supplementary Figure S2: Activated liver stromal cells augment monocyte recruitment 
across HSEC and thereby likely expand hepatic macrophage pool during liver disease. 
Impact of aLMF conditioned media in the tissue model of bidirectional monocyte TEM. 
Collagen matrix was supplemented with conditoned media from aLMF ± prior TNF-α/IFN-γ 
treatment and number of SE and RT monocytes were counted  (A) Total number of cells that 
migrated. TNFa/IFNg supplemented collagen was used to verify that the effects on monocyte 
transmigration were not mediated by TNFa/IFNg itself. (B) Bar graphs representing the 
number RT- and SE-monocytes with either non-supplemented or aLMF (± TNF-α/IFN-γ-
stimulation) CM supplemented collagen matrixes (C). Stacked bar graphs comparing the 
relative fraction of RT and SE monocytes. (mean, SEM, n=3 experiments, p value from 
paired t-test). 
 
Supplementary Table 1: SAGE analysis of transcriptome changes in RT vs SE monocytes 
from ‘classical’ CD14++CD16- monocytes. Selection of genes of interest with at least 10-fold 
regulation between RT and SE monocytes.  
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Supplementary Table 2: SAGE analysis of transcriptome changes in RT vs SE monocytes 
from ‘intermediate’ CD14++CD16+ monocytes. Selection of genes of interest with at least 
10-fold regulation between RT and SE monocytes.  
 
Supplementary Table 3: SAGE analysis of transcriptome changes in RT vs SE monocytes 
from ‘non-classical’ CD14+CD16++ monocytes. Selection of genes of interest with at least 
10-fold regulation between RT and SE monocytes.  
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Manuscript Number: HEP-15-1041 
Supplementary Table1: 
Comparison reverse transmigrating vs. subendothelial CD14++CD16- monocytes 
Higher in SE monocytes 
Fold-change Gene 
70.38 Major histocompatibility complex I, E (HLA-E) 
21,74 CD14 molecule transcript variant I 
19,13 tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B), transcript variant 1, 
18,5216 signal transducer and activator of transcription 2, 113kDa (STAT2), transcript variant 1, 
15,7397 sialic acid binding Ig-like lectin 7 (SIGLEC7), transcript variant 3 
  
Higher in RT monocytes 
Fold-change Gene 
38,41 tumor necrosis factor (TNF) 
29,55 tumor necrosis factor receptor superfamily, member 12A (TNFRSF12A) 
28,57 interleukin 8 (IL8) 
27,55 chemokine (C-C motif) ligand 3 (CCL3) 
24,75 interleukin 1, beta (IL1B) 
24,29 chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) (CXCL1) 
22,35 jun proto-oncogene (JUN) 
19,48 insulin-like growth factor binding protein 7 (IGFBP7) 
18,63 chemokine (C-C motif) ligand 4-like 1 (CCL4L1) 
18,36 chemokine (C-C motif) ligand 3-like 3 (CCL3L3) 
17,00 CD59 molecule, complement regulatory protein (CD59) 
13,64 chemokine (C-X-C motif) ligand 2 (CXCL2) 
Page 44 of 46
Hepatology
Hepatology
This article is protected by copyright. All rights reserved.
Manuscript Number: HEP-15-1041 
Supplemental Table 2: 
Comparison reverse transmigrating vs. subendothelial CD14++CD16+ monocytes 
 
Higher in SE monocytes 
Fold-change Gene 
111,00 S100 calcium binding protein A11 (S100A11) 
62,53 CD14 molecule (CD14), transcript variant 1 
48,75 major histocompatibility complex, class II, DP beta 1 (HLA-DPB1) 
32,54 interferon, gamma-inducible protein 30 (IFI30) 
30,85 colony stimulating factor 1 receptor (CSF1R) 
29,96 major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1) 
29,65 chemokine (C-X-C motif) ligand 16 (CXCL16), transcript variant 1 
29,38 CD63 molecule (CD63), transcript variant 1 
28,99 major histocompatibility complex, class II, DR beta 1 (HLA-DRB1) 
28,81 suppressor of cytokine signaling 7 (SOCS7) 
27,54 interleukin 2 receptor, alpha (IL2RA) 
26,93 plasminogen activator, urokinase receptor (PLAUR), transcript variant 1 
26,75 major histocompatibility complex, class I, E (HLA-E) 
23,59 major histocompatibility complex, class II, DM alpha (HLA-DMA) 
21,76 leukotriene B4 receptor (LTB4R) 
21,06 intercellular adhesion molecule 2 (ICAM2) 
20,57 CD37 molecule (CD37), transcript variant 2 
20,18 CASP8 and FADD-like apoptosis regulator (CFLAR), transcript variant 1 
18,05 major histocompatibility complex, class II, DP alpha 1 (HLA-DPA1), transcript variant 2 
16,31 major histocompatibility complex, class II, DM alpha (HLA-DMA) 
14,26 CD63 molecule (CD63), transcript variant 1 
13,95 caveolin 2 (CAV2), transcript variant 1 
13,92 prostaglandin D2 synthase 21kDa (brain) (PTGDS) 
13,31 CD74 molecule, major histocompatibility complex, class II invariant chain 
12,02 sialic acid binding Ig-like lectin 14 (SIGLEC14) 
11,98 CD244 molecule, natural killer cell receptor 2B4 (CD244), transcript variant 
11,17 major histocompatibility complex, class I, F (HLA-F), transcript variant 2 
  
Higher in RT monocytes 
Fold-change Gene 
1128,92 chemokine (C-C motif) ligand 4-like 1 (CCL4L1) 
659,61 chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) (CXCL1) 
481,94 chemokine (C-X-C motif) ligand 2 (CXCL2) 
394,81 interleukin 8 (IL8) 
206,72 Janus kinase 1 (JAK1) 
187,58 tumor necrosis factor receptor superfamily, member 10b (TNFRSF10B), transcript variant 1,  
168,28 transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 1,  
112,25 interleukin 1, beta (IL1B) 
97,50 tumor necrosis factor, alpha-induced protein 3 (TNFAIP3) 
88,65 jun proto-oncogene (JUN) 
88,23 reactive oxygen species modulator 1 (ROMO1) 
52,32 high mobility group box 1 (HMGB1) 
52,29 CD164 molecule, sialomucin (CD164) 
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50,38 interferon regulatory factor 2 binding protein 2 (IRF2BP2) transcript variant 1 
47,98 CD58 molecule (CD58), transcript variant 1 
Fold-change Gene 
44,99 Fc fragment of IgG, low affinity IIa, receptor (CD32) (FCGR2A), transcript variant 1, 
37,62 CD44 molecule (Indian blood group) (CD44) 
35,50 notch 1 (NOTCH1) 
35,32 myeloid differentiation primary response 88 (MYD88), transcript variant 5,  
34,57 lipopolysaccharide-induced TNF factor (LITAF), transcript variant 1 
34,00 toll-like receptor 2 (TLR2) 
29,17 C-type lectin domain family 10, member A (CLEC10A), transcript variant 2 
27,35 CD9 molecule (CD9) 
25,50 cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) (CDKN2C), transcript variant 1 
24,37 CD40 molecule, TNF receptor superfamily member 5 (CD40), transcript variant 2 
24,13 cyclin-dependent kinase 13 (CDK13) 
23,87 platelet/endothelial cell adhesion molecule 1 (PECAM1) 
20,63 integrin, alpha L (antigen CD11A (p180),  
16,45 prostaglandin E receptor 2 (subtype EP2), 53kDa (PTGER2) 
12,78 Homo sapiens signal transducer and activator of transcription 3 (STAT3), transcript variant 1 
12,01 CD46 molecule, complement regulatory protein (CD46) 
11,31 chemokine (C-C motif) receptor 1 (CCR1) 
11,26 tumor necrosis factor (TNF) 
10,06 heat shock 105kDa/110kDa protein 1 (HSPH1) 
10,05 CD69 molecule (CD69) 
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Supplementary Table 3: 
Comparison reverse transmigrating vs. subendothelial CD14+CD16++ monocytes 
Higher in SE monocytes 
Fold-change Gene 
40,84 CD63 molecule (CD63), transcript variant 1 
23,24 interleukin 2 receptor, gamma (IL2RG) 
22,95 D247 molecule (CD247), transcript variant 1 
11,82 colony stimulating factor 1 receptor (CSF1R) 
  
Higher in RT monocytes 
Fold-change Gene 
122,01 chemokine (C-C motif) ligand 3 (CCL3) 
79,40 chemokine (C-C motif) ligand 4-like 1 (CCL4L1) 
72,62 interleukin 1, beta (IL1B 
53,91 interleukin 8 (IL8) 
39,10 chemokine (C-X-C motif) ligand 2 (CXCL2) 
31,11 chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) (CXCL1) 
22,69 chemokine (C-C motif) ligand 3 (CCL3) 
19,58 tumor necrosis factor, alpha-induced protein 3 (TNFAIP3) 
18,45 tumor necrosis factor, alpha-induced protein 8 (TNFAIP8), transcript variant 1 
14,10 cyclin D1 (CCND1) 
11,97 1 receptor antagonist (IL1RN) 
11,33 complement component 5a receptor 1 (C5AR1) 
10,07 interleukin 10 (IL10) 
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